prescribing information, revised in December 2025, integrates these indications for both injection and tablet formulations, while incorporating updated guidance on severe gastrointestinal events, acute kidney injury, and periprocedural aspiration risk
Starter dose 2.5 mg is on the lower end, maintenance 12.5 to 15 mg is on the higher end
GLP-1 drugs prescribed for purposes other than weight loss (e.g., type 2 diabetes) remain covered under regular Part D with standard cost-sharing rules
El 75-80% de los adolescentes con Obesidad seguirn teniendo Obesidad en la edad adulta si no son tratados
These tools provide a helpful estimate based on common plan structures, but they cannot access your specific, private insurance details